scholarly journals CASE SERIES OF PATIENTS WITH E-CIGARETTE OR VAPING PRODUCT-ASSOCIATED LUNG INJURY: INSIGHTS FROM A SAFETY NET HOSPITAL

CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A2367
Author(s):  
Raghavendra Sanivarapu ◽  
Shiva Arjun ◽  
Hyfaa Mashaal ◽  
Alejandro Gutierrez ◽  
Daniel Meshoyrer ◽  
...  
Cureus ◽  
2020 ◽  
Author(s):  
Ishaan Vohra ◽  
Parth Desai ◽  
Kapil Thapa Chhetri ◽  
Hassam Shah ◽  
Anas Almoghrabi

2018 ◽  
Vol 159 (3) ◽  
pp. 484-493 ◽  
Author(s):  
Haley K. Perlow ◽  
Stephen J. Ramey ◽  
Ben Silver ◽  
Deukwoo Kwon ◽  
Felix M. Chinea ◽  
...  

Objective To examine the impact of treatment setting and demographic factors on oropharyngeal and laryngeal cancer time to treatment initiation (TTI). Study Design Retrospective case series. Setting Safety net hospital and adjacent private academic hospital. Subjects and Methods Demographic, staging, and treatment details were retrospectively collected for 239 patients treated from January 1, 2014, to June 30, 2016. TTI was defined as days between diagnostic biopsy and initiation of curative treatment (defined as first day of radiotherapy [RT], surgery, or chemotherapy). Results On multivariable analysis, safety net hospital treatment (vs private academic hospital treatment), initial diagnosis at outside hospital, and oropharyngeal cancer (vs laryngeal cancer) were all associated with increased TTI. Surgical treatment, severe comorbidity, and both N1 and N2 status were associated with decreased TTI. Conclusion Safety net hospital treatment was associated with increased TTI. No differences in TTI were found when language spoken and socioeconomic status were examined in the overall cohort.


Author(s):  
Vishakha Sabharwal ◽  
Ruby Bartolome ◽  
Sacha Al Hassan ◽  
Bernadette M. Levesque ◽  
Ingrid Y. Camelo ◽  
...  

Objective This study aimed to describe maternal characteristics and clinical outcomes of infants born to mothers with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests during pregnancy at an urban, safety-net hospital in Boston. Study Design We abstracted electronic chart data from 75 pregnant women with positive SARS-CoV-2 tests at any stage of gestation until 72 hours after birth who delivered consecutively between March 31 and August 6, 2020 at our center. We collected clinical data on maternal and infant characteristics, including testing, signs, and symptoms of coronavirus disease 2019 (COVID-19), delivery outcomes, newborn care practices (skin-to-skin care, location of care, and breastfeeding) and 30-day postdischarge infant emergency room visits and readmissions. We described categorical characteristics as percentages for this case series. Results Among 75 pregnant women, 47 (63%) were Hispanic, 10 (13%) had hypertension, 23 (30%) had prepregnancy obesity, and 57 (76%) had symptomatic SARS-CoV-2 infection. Regarding birth outcomes, 32 (41%) had cesarean delivery and 14 (19%) had preterm birth. Among 75 infants, 5 (7%) had positive SARS-CoV-2 polymerase chain reaction tests in the first week of life, all of whom were born to Hispanic mothers with symptomatic SARS-CoV-2 infection and had clinical courses consistent with gestational age. Six (8%) infants visited the emergency department within 30 days of discharge; one was admitted with a non-COVID-19 diagnosis. Conclusion At our urban, safety-net hospital among pregnant women with positive SARS-CoV-2 tests, 41% had a cesarean delivery and 19% had a preterm birth. Seven percent of infants had one or more positive SARS-CoV-2 tests and all infants had clinical courses expected for gestational age. Key Points


2012 ◽  
Vol 1 (4) ◽  
pp. 48-52 ◽  
Author(s):  
Amanda C. Filippelli ◽  
Laura F. White ◽  
Lisa W. Spellman ◽  
Maria Broderick ◽  
Ellen Silver Highfield ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Victoria L. Phillips ◽  
Anil K. Roy ◽  
Jonathan Ratcliff ◽  
Gustavo Pradilla

Objective. We compared the safety and effectiveness of minimally invasive parafascicular surgery (MIPS) as a frontline treatment for spontaneous supratentorial ICH to medical management. Patients. The sample consisted of 17 patients who underwent MIPS from January 2014 to December 2016 and a comparison group of 23 patients who were medically managed from June 2012 to December 2013. All had an International Classification of Disease (ICD) diagnosis of 431 and were treated at Grady Memorial Hospital, an urban, public, safety-net hospital. Methods. The primary endpoint was risk of inpatient mortality. Secondary endpoints were rates of inpatient infection and favorable discharge status, defined as discharge to home or rehabilitation facility. Demographics and pre- and postclinical outcomes were compared using t-tests, the Mann–Whitney test, and chi-squared tests for continuous, ordinal and categorical measures, respectively. Cox proportional hazard models were used to estimate the time to inpatient death. Logistic regression analyses were used to determine treatment effects on secondary outcomes. We also conducted exploratory subgroup analyses which compared MIPS to two medical management subgroups: those who had surgery during their hospitalization and those that did not. Results. Two patients (12%) died in the MIPS group compared to three (12%) in the medical management group. MIPS did not increase the risk of inpatient mortality relative to medical management. Rates of inpatient infection did not differ significantly between the two groups; eight MIPS patients (47%) and 13 medically managed patients (50%) contracted infections. MIPS significantly increased the likelihood of favorable discharge status (odds ratio (OR) 1.77; 95% CI, 1.12–21.9) compared to medical management. No outcome measures were significantly different between MIPS and the medical management subgroup without surgery, while rates of favorable discharge were higher among the MIPS patients compared to the medical management group with surgery. Conclusions. These data suggest that MIPS, as a frontline treatment for spontaneous ICH, versus medical management for spontaneous ICH warrants further investigation.


2020 ◽  
Vol 115 (1) ◽  
pp. S1610-S1610
Author(s):  
Syed S. Karim ◽  
Pranay Srivastava ◽  
Jarin Prasa ◽  
Prashant Jadav ◽  
Bobby Jacob ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1195-P
Author(s):  
ROOPA KALYANARAMAN MARCELLO ◽  
JOHANNA DOLLE ◽  
SHARANJIT KAUR ◽  
SAWKIA R. PATTERSON ◽  
NICHOLA DAVIS

2021 ◽  
Vol 264 ◽  
pp. 117-123
Author(s):  
Katherine F Vallès ◽  
Miriam Y Neufeld ◽  
Elisa Caron ◽  
Sabrina E Sanchez ◽  
Tejal S Brahmbhatt

2021 ◽  
Vol 32 (2) ◽  
pp. 1047-1058
Author(s):  
Andin Josipovic ◽  
Jeffrey Reese ◽  
Erin C. Cantarero ◽  
Christopher S. Elliott

Sign in / Sign up

Export Citation Format

Share Document